This opportunistic bacterium thrives in hospital equipment and can even survive on soap.
In short: Pseudomonas aeruginosa is a master of adaptation, capable of infecting everything from burn wounds to lungs in patients with cystic fibrosis. While it is not inherently as virulent as some other pathogens, its ability to form resilient biofilms and resist multiple antibiotics makes it a formidable clinical challenge.
Pseudomonas aeruginosa is a Gram-negative bacterium recognized for its versatility and ubiquity. It thrives in diverse environments, including soil, water, and human-made settings like catheters and soap. As an opportunistic pathogen, it primarily targets immunocompromised individuals or those with existing conditions such as cancer, chronic obstructive pulmonary disorder, or severe burn wounds. In clinical settings, it is a significant cause of hospital-acquired infections, including ventilator-associated pneumonia.
The bacterium's success as a pathogen is driven by an adaptable arsenal of virulence factors, including lipopolysaccharides, quorum sensing systems, and the ability to aggregate into enduring biofilms. These structures protect the bacteria from host immune responses and antimicrobial agents. Furthermore, P. aeruginosa possesses advanced mechanisms for antibiotic resistance, such as efflux systems and the production of enzymes like carbapenemases, which can render common treatments ineffective. This resistance can be shared between bacteria, facilitating the spread of multi-drug resistant strains.
Researchers are currently employing advanced technologies—including bioinformatics, phage therapy, and nanoparticle-based drug delivery—to better understand the pathogen's molecular mechanisms and host-pathogen interactions. Because P. aeruginosa can rapidly evolve and adapt, particularly in chronic infection environments like the lungs of cystic fibrosis patients, developing effective, mechanism-tested therapeutics remains a high priority for global health. Understanding how these bacteria manipulate host signaling pathways is essential for designing the next generation of treatments to combat intractable, multi-drug resistant infections.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics - Signal Transduction and Targeted Therapy
- Also: What Is a Pseudomonas aeruginosa Infection?
- Also: Pseudomonas aeruginosa
To cite this card, link to https://intellectplus.co.uk/app/gardening-pseudomonas-aeruginosa.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Prokaryotes · More in Gardening · Latest · A–Z · All topics